**To the Editor:** We noted the report by Chowdhary et al. ([@R1]) and report *Candida auris* as a causative agent of candidemia in South Africa, with an estimated prevalence of 0.3% (N.P. Govender et al., unpub. data). First isolated in 2009, *C. auris* is an emerging species associated with clinical disease ([@R2]--[@R6]). We analyzed 4 isolates submitted to the National Institute for Communicable Diseases (Johannesburg, South Africa) from 4 patients with candidemia who had been admitted to different public- and private-sector hospitals from October 2012 through October 2013.

Identification of the isolates was undertaken by using ChromAgar *Candida* medium (Mast Diagnostics, Merseyside, UK), Vitek-2 YST (bioMérieux, Marcy ľEtoile, France), API 20C AUX (bioMérieux), and sequencing of internal transcribed spacer (ITS) and D1/D2 domains of the ribosomal RNA gene ([@R7]), followed by microbroth dilution susceptibility testing ([@R8]). All isolates were misidentified as *C. haemulonii* and *Rhodotorula glutinis* by Vitek-2 YST and API 20C AUX assays, respectively ([Table](#T1){ref-type="table"}).

###### Identification and antifungal susceptibility results of 4 *Candida auris* isolates from 4 male patients with candidemia, South Africa, October 2012--October 2013\*

  Isolate ID   Patient age, y   Hospital unit   Vitek-2 YST†      API 20C AUX†             DNA sequence analysis‡   MIC                                                      
  ------------ ---------------- --------------- ----------------- ------------------------ ------------------------ ----- ------- ------ ------- ------ ------ ------ ------ ------
  208          85               High-care       *C. haemulonii*   *Rhodotorula glutinis*   *C. auris*               1     \>256   0.5    0.03    0.12   0.12   0.25   0.06   0.25
  209          60               Medical ICU     *C. haemulonii*   *R. glutinis*            *C. auris*               0.5   \>256   1      0.06    0.12   0.12   0.12   0.06   0.12
  224          73               Burn            *C. haemulonii*   *R. glutinis*            *C. auris*               1     \>256   2      0.06    0.25   0.12   0.25   0.12   0.25
  293          27               Trauma ICU      *C. haemulonii*   *R. glutinis*            *C. auris*               1     64      0.25   0.015   0.06   0.06   0.03   0.06   0.06

\*AMB, amphotericin B; FLX, fluconazole; VRC, voriconazole; POS, posaconazole; ITC, itraconazole; 5FC, flucytosine; CAS, caspofungin; MFG, micafungin; AFG, anidulafungin. †bioMérieux, Marcy ľEtoile, France. ‡Sequence data for the 4 isolates have been deposited in GenBank, accession nos. KJ1236762--KJ126765 and KJ126758--KJ126761 for the internal transcribed spacer and D1/D2 regions, respectively.

Similar to the findings of Chowdhary et al., all isolates assimilated *N*-acetyl-glucosamine ([@R1]). With the use of the CBS-KNAW database, pairwise sequence alignment of ITS region showed 99% sequence homology to Kuwait isolates, and alignment of D1/D2 domain showed 98% homology to the Kuwait/India isolates ([@R9]). In a neighbor-joining phylogenetic tree based on ITS sequences, South Africa isolates formed a cluster with India and Kuwait isolates ([Technical Appendix](#SD1){ref-type="local-data"}Figure).

Fluconazole MICs were high for all isolates ([Table](#T1){ref-type="table"}). Isolates 209 and 224 showed reduced voriconazole susceptibility with MICs of 1 μg/mL and 2 μg/mL, respectively, which is above the epidemiologic cutoff value for 11 *Candida* species ([@R10]). Isolates were susceptible to amphotericin B and echinocandins at low MICs Clinical data were available for 1 patient ([Technical Appendix](#SD1){ref-type="local-data"} Table). Two *C. haemulonii* isolates were identified during laboratory-based sentinel surveillance for candidemia in South Africa; the ITS region of one isolate was sequenced and the isolate identified as C. auris (N.P. Govender, pers. comm.). In this study, *C. auris* was misidentified by routinely used tests and was accurately identified by sequencing, in keeping with previous findings ([@R1],[@R3],[@R4],[@R6]).

###### Technical Appendix

Phylogenetic relatedness of internal transcribed spacer region of the ribosomal RNA gene of *Candida auris* with closely related *Candida* species and clinical characteristics of a patient with candidemia caused by *C. auris*, South Africa.
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